Cargando…
Association between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature review
Emerging evidence indicates that Retinoic acid receptor-β (RARβ) is a tumor suppressor in many types of tumor. However, whether or not RARβ is a risk factor and is correlated to clinicopathological characteristics of non-small cell lung cancer (NSCLC) remains unclear. In this report, we performed a...
Autores principales: | Li, Yan, Lu, De-guo, Ma, Ying-mei, Liu, Hongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351591/ https://www.ncbi.nlm.nih.gov/pubmed/28008143 http://dx.doi.org/10.18632/oncotarget.14023 |
Ejemplares similares
-
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
por: Huebner, H., et al.
Publicado: (2017) -
Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review
por: Guo, Hao, et al.
Publicado: (2016) -
METH-2 silencing and promoter hypermethylation in NSCLC
por: Dunn, J R, et al.
Publicado: (2004) -
Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids
por: Tsai, Yueh-Ju, et al.
Publicado: (2015) -
2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia
por: Lu, Ying, et al.
Publicado: (2019)